Association between Argyrophilic Proteins of Nucleolar Organizer Regions, Clinicomorphological Parameters, and Survival in Non-Small-Cell Lung Cancer.

Dmitriy Kobyakov,Aleksandr Lazarev,Ashot Avdalyan,Lev Nepomnyashchikh,Natalia Kruglova,Elena Bychkova,Vladimir Klimachev,Igor Bobrov,Elena Lushnikova

doi:10.1155/2014/891917

Abstract

We studied argyrophilic proteins associated with nucleolar organizer regions (AgNOR) in non-small-cell cancer. We determined the area index (AI) and coefficient of variation (CV) of AgNOR. AI is associated with the key clinicomorphological parameters within the TNM system: T and N values, greatest tumor dimension up to 3 cm and more, disease stage, histogenesis, and tumor differentiation. CV is associated with T value, greatest tumor dimension up to 3 cm and more, histogenesis, and tumor differentiation. Survival of patients is longer in low AI or CV values versus high AI or CV values, longer in low AI and CV values (−AI/−CV type), shorter in high AI and CV values (+AI/+CV type), and intermediate in opposite AI and CV values (−AI/+CV and +AI/−CV types). Independent predictors in non-small-cell lung cancer include N value, greatest tumor dimension, histogenesis, and CV. Assessment of quantitative values and heterogeneity of AgNOR is important for differential diagnosis and prognosis of non-small-cell lung cancer.

Highlights

Lung cancer is a prevailing malignancy, with 80% of cases being non-small-cell cancer
Evaluation of argyrophilic proteins associated with nucleolar organizer regions (AgNOR) is a generally established marker of proliferative activity and the cell cycle rate
The result of slice staining with silver nitrate was determined as roundish black granules (AgNOR) located against the background of a brown nucleole or pale yellow nucleus (Figure 1)

Summary

Introduction

Lung cancer is a prevailing malignancy, with 80% of cases being non-small-cell cancer. Long-term treatment outcomes and survival of patients with non-small-cell cancer leave much to be desired. It is important to study morphological criteria related to the key clinicomorphological parameters of tumor and non-small-cell lung cancer patient survival and more accurate ways of predicting the course of the disease [1]. Up to 75% of AgNOR staining is made by the two argyrophilic proteins: C23 (nucleolin) and B23 (nucleophosmin), playing a key role in ribosomal RNA synthesis. These proteins are detected in cell nuclei for the whole duration of the cell cycle, with a 1.5–3-fold increase occurring during S- and G2phases [2]. Inverse relationship between quantitative amount of AgNOR and the cell cycle duration [3], doubling time of the tumor cell mass [4, 5], has been shown

Objectives

Methods

Results